These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 3736552

  • 1. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A, Koch H, Haberbosch W, Fellin R, Postiglione A, Augustin J.
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract] [Full Text] [Related]

  • 2. [Chylomicronemia].
    Yamamoto T, Kawakami M.
    Nihon Rinsho; 1990 Nov; 48(11):2526-31. PubMed ID: 2270016
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)].
    Bakker HD, Abeling NG, Rammeloo JA, Jansen H, van Gennip AH.
    Ned Tijdschr Geneeskd; 1985 Apr 06; 129(14):642-5. PubMed ID: 3990858
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
    Stalenhoef AF, Casparie AF, Demacker PN, Stouten JT, Lutterman JA, van 't Laar A.
    Metabolism; 1981 Sep 06; 30(9):919-26. PubMed ID: 7266379
    [Abstract] [Full Text] [Related]

  • 7. Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype.
    Berger GM, Van der Westhuyzen JH, Huskisson J, Bonnici F, Henderson HE.
    S Afr Med J; 1982 Feb 20; 61(8):266-72. PubMed ID: 7058458
    [Abstract] [Full Text] [Related]

  • 8. [Hyperlipoproteinemia type I].
    Bustos P, Fernández E, Radrigán E.
    Rev Chil Pediatr; 1987 Feb 20; 58(6):481-4. PubMed ID: 3506219
    [No Abstract] [Full Text] [Related]

  • 9. [Apolipoprotein C-II deficiency].
    Yamamura T.
    Ryoikibetsu Shokogun Shirizu; 1998 Feb 20; (19 Pt 2):50-3. PubMed ID: 9645006
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II.
    Reckless JP, Stocks J, Holdsworth G, Galton DJ, Suggett AJ, Walton KW.
    Clin Sci (Lond); 1982 Jan 20; 62(1):93-100. PubMed ID: 7056035
    [Abstract] [Full Text] [Related]

  • 13. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L, Karádi I, Simonyi E.
    Orv Hetil; 1980 Oct 26; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract] [Full Text] [Related]

  • 14. Chylomicronemia syndrome.
    Chait A, Brunzell JD.
    Adv Intern Med; 1992 Oct 26; 37():249-73. PubMed ID: 1557997
    [Abstract] [Full Text] [Related]

  • 15. Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
    Wiebusch H, Funke H, Bruin T, Bucher H, von Eckardstein A, Kastelein JJ, Assmann G.
    Hum Mutat; 1996 Oct 26; 8(4):381-3. PubMed ID: 8956048
    [No Abstract] [Full Text] [Related]

  • 16. [Familial hyperchylomicronemia syndrome].
    Tada N.
    Nihon Rinsho; 2001 Mar 26; 59 Suppl 3():13-21. PubMed ID: 11347044
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Chylomicronemia syndrome--pathophysiology, clinical aspects and therapy].
    Klör HU.
    Klin Wochenschr; 1990 Mar 26; 68 Suppl 22():68-75. PubMed ID: 2087083
    [No Abstract] [Full Text] [Related]

  • 19. Lipoprotein lipase with a defect in lipid interface recognition in a case with type I hyperlipidaemia.
    Kobayashi J, Shirai K, Saito Y, Yoshida S.
    Eur J Clin Invest; 1989 Oct 26; 19(5):424-32. PubMed ID: 2511018
    [Abstract] [Full Text] [Related]

  • 20. Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion.
    Miller NE, Rao SN, Alaupovic P, Noble N, Slack J, Brunzell JD, Lewis B.
    Eur J Clin Invest; 1981 Feb 26; 11(1):69-76. PubMed ID: 6783432
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.